IGF2BP3 and rheumatoid arthritis: To explore the role of IGF2BP3‐mediated mTORC1 activation in CEL‐mediated regulation of cell proliferation and inflammatory activation, we administered CEL and the mTORC1 activator, MHY1485, in RA‐FLS.